FdaApplication
ANDA 214827
Identifiers
- fda_app_no: ANDA214827
Properties
| Property | Value |
|---|---|
| applicant_name | MSN LABORATORIES PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2022-01-27 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 50MG | TABLET;ORAL |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 100MG | TABLET;ORAL |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 200MG | TABLET;ORAL |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 25MG | TABLET;ORAL |
4 products